Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark

被引:0
|
作者
Cathrine F. Hjorth
Per Damkier
Tore B. Stage
Søren Feddersen
Stephen Hamilton-Dutoit
Mikael Rørth
Bent Ejlertsen
Timothy L. Lash
Thomas P. Ahern
Henrik T. Sørensen
Deirdre Cronin-Fenton
机构
[1] Aarhus University Hospital,Department of Clinical Medicine and Department of Clinical Epidemiology
[2] Aarhus University,Department of Clinical Pharmacology
[3] Odense University Hospital,Department of Clinical Research
[4] University of Southern Denmark,Department of Public Health
[5] University of Southern Denmark,Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health
[6] University of Southern Denmark Odense,Department of Clinical Biochemistry
[7] Odense University Hospital,Department of Pathology
[8] Aarhus University Hospital,Department of Oncology, Rigshospitalet
[9] Copenhagen University,Danish Breast Cancer Group, Rigshospitalet
[10] Copenhagen University Hospital,Department of Epidemiology, Rollins School of Public Health
[11] Emory University,Department of Surgery, The Robert Larner, M.D. College of Medicine
[12] The University of Vermont,undefined
来源
关键词
Breast neoplasm; Taxanes; Single-nucleotide polymorphisms; Mortality; Neoplasm recurrence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:353 / 363
页数:10
相关论文
共 50 条
  • [31] Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review
    Ricardo Fernandes
    Sasha Mazzarello
    Brian Hutton
    Risa Shorr
    Habeeb Majeed
    Mohammed FK Ibrahim
    Carmel Jacobs
    Michael Ong
    Mark Clemons
    Supportive Care in Cancer, 2016, 24 : 3633 - 3650
  • [32] Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population
    Driver, Kristy E.
    Song, Honglin
    Lesueur, Fabienne
    Ahmed, Shahana
    Barbosa-Morais, Nuno L.
    Tyrer, Jonathan P.
    Ponder, Bruce A. J.
    Easton, Douglas F.
    Pharoah, Paul D. P.
    Dunning, Alison M.
    CARCINOGENESIS, 2008, 29 (02) : 333 - 341
  • [33] Endometrial cancer in premenopausal women- a nationwide population-based cohort study
    Ioannou, Chrysanthos
    Malmsten, Cecilia
    Ehn, Per
    Holmberg, Erik
    Kahler, Pernilla Dahm
    Stalberg, Karin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A184 - A185
  • [34] Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
    Liao, Yuqian
    Liao, Yulu
    Li, Jun
    Li, Junyu
    Fan, Ying
    Xu, Binghe
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3801 - 3808
  • [35] Risk of type 2 diabetes after breast cancer treatment: a population-based cohort study in Denmark
    Kjaergaard, Kasper A.
    Kousholt, Astrid
    Thomsen, Reimar W.
    Woolpert, Kirsten M.
    Sorensen, Henrik T.
    Borgquist, Signe
    Cronin-Fenton, Deirdre
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024,
  • [36] Anti-Mullerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A study
    Trapp, Elisabeth
    Steidl, J.
    Rack, B.
    Kupka, M. S.
    Andergassen, U.
    Jueckstock, J.
    Kurt, A.
    Vilsmaier, T.
    de Gregorio, A.
    de Gregorio, N.
    Tzschaschel, M.
    Lato, C.
    Polasik, A.
    Tesch, H.
    Schneeweiss, A.
    Beckmann, M. W.
    Fasching, P. A.
    Janni, W.
    Mueller, V.
    BREAST, 2017, 35 : 130 - 135
  • [37] IGF2R Missense Single-Nucleotide Polymorphisms and Breast Cancer Risk: The Multiethnic Cohort Study
    Cheng, Iona
    Stram, Daniel O.
    Burtt, Noel P.
    Gianniny, Lauren
    Garcia, Rachel R.
    Pooler, Loreall
    Henderson, Brian E.
    Le Marchand, Loic
    Haiman, Christopher A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (06) : 1922 - 1924
  • [38] Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study
    Heer, Emily
    Harper, Andrew
    Escandor, Noah
    Sung, Hyuna
    McCormack, Valerie
    Fidler-Benaoudia, Miranda M.
    LANCET GLOBAL HEALTH, 2020, 8 (08): : 1027 - 1037
  • [39] First-line Bevacizumab Plus Taxane-based Chemotherapy for Metastatic Breast Cancer (mBC)
    Bazan, F.
    Dobi, E.
    Villanueva, C.
    Nerich, V.
    Compagnat, F.
    Thiery-Vuillemin, A.
    Chaigneau, L.
    Nguyen, T.
    Limat, S.
    Pivot, X.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S345 - S345
  • [40] Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer
    J. M. Andrade
    H. H. A. Carrara
    F. F. Pimentel
    H. R. C. Marana
    A. H. Macchetti
    L. R. Mouro
    F. E. Zola
    D. G. Tiezzi
    Medical Oncology, 2011, 28 : 65 - 69